A previous network meta-analysis demonstrated that, for patients with HF and an LVEF of 40% or more, ARNIs and ACE inhibitors were associated with a significant decrease in the risk of hospital admission for HF, but MRAs were not.14 These results are partly inconsistent with the results of our analysis. This evidence concerns the gene ACE and hydrops fetalis.